Toxys is a Leiden, The Netherlands-based biotech that develops animal-free mechanistic in vitro safety tests, led by CEO Giel Hendriks. Its patented ToxTracker® assay can identify toxic and carcinogenic properties of novel pharmaceuticals, agrochemicals and fine chemicals at early development stages. The company provides expert mechanistic in vitro chemical safety testing services for medicines, chemicals and consumer products. ToxTracker® is currently under review by international authorities for potential official acceptance and inclusion within standard regulatory safety test strategies. Toxys intends to use new funding to expand operations in Europe and the United States, broaden its portfolio of in vitro toxicology assays, and speed up international growth. The company plans to work on acceptance and implementation of its assays for regulatory applications.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2020